1. Articles in category: Other Business News

    1-24 of 1028 1 2 3 4 ... 41 42 43 »

    1. Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Optovue Unveils New AngioVue Essential OCTA at the International Vision Expo

      Optovue , the global leader in the development of optical coherence tomography ( OCT ) and OCT angiography ( OCTA ), will debut its AngioVue® Essential OCTA capability for optometry and general ophthalmology at the upcoming International Vision Expo & Conference 2017 in Las Vegas. AngioVue Essential aids clinicians’ ability to visualize ocular disease by providing high-resolution, non-invasive imaging of retinal vasculature. Optimized for optometry and general ophthalmology practices, AngioVue Essential provides fundamental OCTA features in a single-page report that displays individual layers of retinal vasculature alongside structural OCT B-scans. As a result, clinicians can quickly transform a basic eye exam into a comprehensive assessment of ...

      Read Full Article
      Mentions: Optovue

    2. Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Optovue First in US to Receive FDA Clearance for Corneal Epithelial Thickness Mapping New Mapping Technique May be Early Indicator of Ocular Health

      Optovue announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s epithelial thickness mapping software (epi-mapping) for quantitative measurements of the epithelial and stromal layers of the cornea. Epi-mapping is the first non-contact, quantitative method for corneal epithelia and stromal measurements, and it is the first and only FDA-cleared product indicated to provide corneal epithelia and stromal measurements that aid in the diagnosis, documentation and management of ocular health and diseases in the adult population. “The measurement of corneal epithelial thickness is becoming more recognized as a vital part of assessing patients for refractive ...

      Read Full Article
      Mentions: Optovue Jay Wei FDA

    3. Notal Vision Welcomes Roni Amiel as Chief Information Officer

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Notal Vision Welcomes Roni Amiel as Chief Information Officer

      Notal Vision, Ltd., a privately-held ophthalmic company focused on cloud-based, patient-activated, home telemonitoring technologies, is pleased to announce the appointment of Roni Amiel as Chief Information Officer (CIO). In this newly created position, Mr. Amiel will be responsible for advancing the Company's cloud-based technology and capabilities to expand their competitive advantage, and will report to Quinton Oswald , Chief Executive Officer of Notal Vision. "Drawing on his extensive information technology (IT) leadership and medical systems expertise, Roni will help us execute our strategic goals so that we can continue to deliver an outstanding patient and physician experience. Elevating this IT ...

      Read Full Article
      Mentions: Notal Vision

    4. Michelson Diagnostics Secures CPT codes for Optical Coherence Tomography Imaging of Skin

      Explore Optical Coherence Tomography News Dermatology , Other Business News
      Michelson Diagnostics Secures CPT codes for Optical Coherence Tomography Imaging of Skin

      Michelson Diagnostics announces that the American Medical Association (AMA) CPT Editorial Panel recently approved two new Category III CPT codes for Optical Coherence Tomography (OCT) imaging of skin. Code 0470T is for OCT microstructural and morphological imaging of skin, image acquisition, interpretation and report for a first lesion; code 0471T is the same for each additional lesion. The new Category III codes, which are for emerging technologies, services, and procedures, are effective July 1, 2017. Michelson Diagnostics pursued approval of this code at the AMA CPT Panel meeting in October 2017, receiving support from the American Academy of Dermatology. “Obtaining ...

      Read Full Article
      Mentions: Michelson Diagnostics Jon Holmes FDA

    5. NKT Photonics to acquire Onefive, a leading supplier of ultrafast lasers

      Explore Optical Coherence Tomography News Acquisition , Other Business News
      NKT Photonics to acquire Onefive, a leading supplier of ultrafast lasers

      NKT Photonics has entered into an agreement to acquire Onefive, a leading ultrafast laser manufacturer headquartered in Zurich, Switzerland. The acquisition will strengthen NKT Photonics’ Material Processing business by adding complementary know-how and products to the portfolio. Founded in 2005, Onefive has a strong product portfolio within ultrafast lasers, especially within femto- and picosecond systems. Onefive’s customers are mainly in the medical and life science segments, but they also supply lasers to the industrial material processing and the scientific markets. The company employs 41 people mainly in Zurich, where the main production facilities are located, and in a smaller ...

      Read Full Article
      Mentions: NKT Photonics Fianium

    6. New SuperK MIR brings supercontinuum into the mid-IR

      Explore NKT Photonics Other Business News , Broadband Sources
      New SuperK MIR brings supercontinuum into the mid-IR

      With their ultra-broad spectrum, diffraction-limited beam quality and robust fiber architecture, supercontinuum white light lasers have long been the light source of choice in demanding applications from fluorescence microscopy and bio-imaging to spectroscopy and industrial metrology. Based on NKT Photonics proven supercontinuum platform, the new SuperK MIR now offers the same benefits as the visible and near-infrared sources with an output in the mid-infrared. The SuperK MIR laser delivers more than 450 mW of continuous light from 0.9 to 4.2 μm. The source features a monolithic all-fiber architecture ensuring stability and maintenance-free operation over thousands of hours. The ...

      Read Full Article
      Mentions: NKT Photonics

    7. Compact Optical Delay Line for More Efficient OCT Imaging from Gooch & Housego

      Explore goochandhousego.com Other Business News
      Compact Optical Delay Line for More Efficient OCT Imaging from Gooch & Housego

      Systems Technology Groups presents the G&H small form factor (SFF) delay line. The delay line was specifically designed for the exacting requirements of optical coherence tomography (OCT). OCT is an imaging modality, mainly used in biomedical applications. By using OCT, it is possible to take real-time, high resolution 3D images in a non-invasive manner. OCT is a technique that utilises optical interferometry in which one interferometer arm is the reference optical path and the other is the optical path to the sample being imaged. The technique relies on the precise length alignment between the paths of the two interfering ...

      Read Full Article
      Mentions: Gooch & Housego

    8. Zeiss Acquisition of Insight Ophthalmic Laser Engines for 19.1M Euros

      Explore Optical Coherence Tomography News Acquisition , Other Business News
      Zeiss Acquisition of Insight Ophthalmic Laser Engines for 19.1M Euros

      On 24 February 2017 a contract was concluded between Carl Zeiss Meditec, Inc., Dublin USA, and Insight Photonics Solutions, Inc. (hereinafter “Insight”), which domiciled in Lafayette, USA, pertaining to the acquisition of 52 percent of the shares in Ophthalmic Laser Engines, LLC, Lafayette, USA (hereinafter referred to as “OLE”). The main aim of acquiring these shares is to develop and produce an akinetic swept source laser for ophthalmology, and the associated OCT system elements. Departing from the voting rights distribution, a profit distribution of 30% for Insight was agreed until 31 December 2022, which allocated as a performance-related component to ...

      Read Full Article
      Mentions: Carl Zeiss Meditec Insight Photonic Solutions

    9. Axsun Hopes to Break Into the 3D Printing Market | 3D Print Plan

      Explore 3D Print Plan NDE/NDT , Other Business News
      Axsun Hopes to Break Into the 3D Printing Market | 3D Print Plan

      Axsun is a 100-person Boston-based company that specializes in “advanced photonics”, a science involving light and microscopic devices. Their technology uses “Optical Coherence Tomography (OCT)” in a way that could benefit 3D print operations. This technology is well-established in the medical community, where it is used to capture highly detailed images of sub-surface structures in transparent or translucent materials. Normally, this is used to “see” into patients for medical diagnoses. Specialized lasers provide the imaging through materials. However, the theory is that it could also be used in 3D printing. Axsun’s proposition is that this technology could be added ...

      Read Full Article
      Mentions: Axsun Technologies

    10. OncoRes Medical backed by MRCF to develop innovative imaging technology for breast cancer surgery

      Explore docs.wixstatic.com Funding , Other Business News
      OncoRes Medical backed by MRCF to develop innovative imaging technology for breast cancer surgery

      OncoRes Medical Pty Ltd, a new medical device company established to develop an imaging tool to improve the outcome of breast cancer surgery, will receive up to AU$6M of venture capital investment from the Medical Research Commercialisation Fund (MRCF). The funding will go towards developing a handheld imaging probe and console which will provide real-time intraoperative guidance to surgeons by assisting with the delineation of tumour from healthy tissue, at a microscopic level. Breast cancer has the second highest mortality rate of all cancers in women. In 2016 there were approximately 16,000 new cases of breast cancer diagnosed ...

      Read Full Article
      Mentions: David D. Sampson University of Western Australia Robert A. McLaughlin

    11. Avinger Announces Verified Data of 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Explore Avinger Cardiology , Other Business News
      Avinger Announces Verified Data of 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced positive two-year clinical data from the pivotal VISION study of the company’s Lumivascular™ technology. The VISION study was designed to evaluate the safety and effectiveness of Avinger’s Pantheris® system to perform directional atherectomy while, for the first time ever, allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Data from the study, which demonstrated successful achievement of all primary and secondary safety and effectiveness endpoints, supported U.S. Food and Drug ...

      Read Full Article
      Mentions: FDA Avinger

    13. NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      Explore NinePoint Medical Gastroenterology , Other Business News
      NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time Targeting™ at DDW 2017; Twenty-four Scientific Abstracts to be Presented

      – NinePoint Medical, Inc., a transformative medical device company pioneering the use of advanced Optical Coherence Tomography (OCT) for gastrointestinal applications, will be featuring the NvisionVLE® Imaging System with Real-time Targeting™ at Digestive Disease Week® (DDW) 2017, which will be held May 6-9 in Chicago. In addition, results from various studies utilizing this technology in gastroenterology will be presented in 24 scientific abstracts throughout the conference. Random biopsy is the current standard of care for diagnosing esophageal diseases such as Barrett’s esophagus, squamous cell carcinoma, and adenocarcinoma. However, random biopsies assess less than 3% of the esophageal surface1 , leaving more ...

      Read Full Article
      Mentions: UC Irvine NinePoint Medical Patrick MacCarthy

    14. Pioneering HD updates launched for the AngioVue OCT-A system

      Explore uk.prweb.com Ophthalmology , Other Business News
      Pioneering HD updates launched for the AngioVue OCT-A system

      Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the launch of AngioVueHD imaging. This high density OCT Angiography (OCT-A) imaging will provide significant improvement in the resolution and peripheral visualisation of vasculature in the eye. AngioVue HD imaging provides OCT-A scans with 73% more sampling points, providing the user with a 6mm x 6mm scan with outstanding resolution. It also improves image resolution by approximately 33% over the existing field-of-view. The improvements enable physicians to more closely assess the fine vasculature in the eye for changes which could indicate ocular ...

      Read Full Article
      Mentions: Optovue Haag-Streit

    15. Teledyne e2v launches new OctoPlus line scan cameras for Optical Coherence Tomography - e2v

      Explore e2v.com Other Business News
      Teledyne e2v launches new OctoPlus line scan cameras for Optical Coherence Tomography - e2v

      eledyne e2v , the global innovator of imaging solutions, has developed a new range of line scan cameras for Optical Coherence Tomography (OCT) applications in healthcare and industrial markets. The new OctoPlus range will have an immediate impact in ophthalmic OCT by reducing patient examination times and increasing the field of view available to practitioners when carrying out non-invasive eye examinations. OctoPlus was developed following discussions with doctors and medical industry professionals. It is based on new image sensor pixel architecture and is specifically tuned to provide users with the most accurate images of the retina and cornea; mapping tissue structure ...

      Read Full Article
      Mentions: e2v

    16. Damae Medical Raises €2M in Funding

      Explore Optical Coherence Tomography News Dermatology , Funding , Other Business News
      Damae Medical Raises €2M in Funding

      Damae Medical , a Paris, France-based medtech company, closed a €2m funding. Backers included Kurma Partners, Idinvest Partners, News Invest, Paris-Saclay Seed Fund co-managed by Partech Ventures, and private investors. The company intends to use the funds to finance the development and CE marking of OCTAV®, which is scheduled for mid-2018. Founded in September 2014 by Anaïs Barut, CEO, Damae Medical aims to provide dermatologists with a novel, in vivo imaging technology for a deep look into the skin. This technology enables cellular-resolution imaging of the skin similar to histology, without the need for tissue excision and processing. The company ...

      Read Full Article
      Mentions: Arnaud Dubois Damae Medical

    17. OPTOVUE FIRST TO RELEASE HIGH DENSITY OCT ANGIOGRAPHY FOR OPHTHALMOLOGY

      Explore Welcome to Optovue Ophthalmology , Other Business News
      OPTOVUE FIRST TO RELEASE HIGH DENSITY OCT ANGIOGRAPHY FOR OPHTHALMOLOGY

      Optovue, the global leader in the development of optical coherence tomography (OCT) and OCT angiography (OCTA) , is the first company to offer higher density OCTA imaging that provides significant improvement in resolution and peripheral visualization of vasculature in the eye. AngioVueHD Imaging, commercially released by Optovue today, provides OCTA scans with 73 percent more sampling points* and improves image resolution by approximately 33 percent over the existing field-of-view, enabling physicians to more closely assess the fine vasculature in the eye for changes that could indicate ocular disease. According to Nadia Waheed, M.D., MPH, associate professor of Ophthalmology at Tufts ...

      Read Full Article
      Mentions: Optovue Jay Wei Nadia K. Waheed

    18. Avinger’s Pantheris Named a 2017 Gold Edison Award Winner

      Explore GlobeNewswire, Inc. Cardiology , Other Business News
      Avinger’s Pantheris Named a 2017 Gold Edison Award Winner

      Avinger, Inc., a leading developer of innovative treatments for peripheral artery disease (PAD), was honored at the 2017 Edison Awards™ in the Medical/Dental Surgical Tool category with gold for Pantheris, the first-ever image-guided atherectomy device for the treatment of PAD. Avinger was nominated among hundreds of the world’s most recognized companies to acknowledge dedication and commitment of innovation to create a positive impact in the world. The ballot of nominees for the Edison Awards was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of ...

      Read Full Article
      Mentions: John B. Simpson Avinger

    19. Second-Generation OCT Module Goes the Extra Mile

      Explore retinalphysician.com Ophthalmology , Other Business News
      Second-Generation OCT Module Goes the Extra Mile

      Device features increased speed and higher image contrast. D avid M. Brown, MD, a retinal physician with Retina Consultants of Houston, in Texas, was prompted to upgrade to Heidelberg Engineering’s OCT2 module for the Spectralis diagnostic imaging platform because of its increased scanning speed and throughput. “I increasingly found that the process of obtaining optical coherence tomography (OCT) caused patient flow to bottleneck at my practice,” he says. “The OCT2 module helps to mitigate that issue. I can obtain a complete volume scan within 12 to 15 seconds for each eye that is precisely image tracked to the last ...

      Read Full Article
      Mentions: Heidelberg Engineering Baylor College of Medicine Heidelberg Spectralis

    20. Avinger to lay off a third of workforce

      Explore massdevice.com Cardiology , Other Business News
      Avinger to lay off a third of workforce

      Avinger said yesterday that it plans to lay off a third of its workforce and examine its “strategic alternatives” as it focuses on its Pantheris peripheral artery device. The layoffs, affecting 131 workers, are slated to be complete this week, the Redwood City, Calif.-based company said, including cutting its field sales force by nearly half, from 60 to 32. “The plan is designed to focus the company’s commercial efforts on driving catheter utilization in its strongest markets, around its most productive sales professionals,” Avinger said. “This workforce reduction is designed to reduce operating expenses while continuing to support ...

      Read Full Article
      Mentions: Avinger

    21. Wasatch Photonics’ MicroAngio System

      Explore Wasatch Photonics Other Business News
      Wasatch Photonics’ MicroAngio System

      Wasatch Photonics’ MicroAngio technology, specifically designed for research and OEM applications, provides a unique way to image micro vascular structures in living tissue. The technique based on optical coherence tomography (OCT) , requires no external contrast agents, and develops a three-dimensional map of the blood vessels. MicroAngio relies on the intrinsic contrast of red blood cell motion in the vessels. This eliminates the requirement of injecting contrast agents and overcomes the problem of background signal from leaky blood vessels. WP MicroAngio, unlike other OCT angiography systems, is custom designed for the specific application. Signal acquisition and processing for such techniques depend ...

      Read Full Article
      Mentions: Wasatch Photonics

    22. The Best Motivations for Photonics Entrepreneurs - An interview with Eric Swanson

      Explore Laser Focus World Other Business News
      The Best Motivations for Photonics Entrepreneurs - An interview with Eric Swanson

      I figure we have much to learn from a very successful serial photonics entrepreneur, Eric Swanson. Eric is a co-founder or founding board member of five companies: Advanced Ophthalmic Devices, Lightlab Imaging, Sycamore Networks, Acacia Communications, and Curata. These companies have evolved over time and shipped over $1 billion in products worldwide. He is an OSA Fellow, IEEE Fellow, a co-recipient of the 2017 Russ Prize, and an active participant in a variety of volunteer activities. Milton Chang: It is remarkable that OCT has been able to move in 25 years from proof-of-principle to an FDA-approved instrument used pervasively in ...

      Read Full Article
      Mentions: Eric A. Swanson St. Jude Medical

    23. Wasatch Photonics Unleashes Game Changing Spectral-domain OCT Spectrometer

      Explore Optical Coherence Tomography News Other Business News
      Wasatch Photonics Unleashes Game Changing Spectral-domain OCT Spectrometer

      Wasatch Photonics Inc. announced its new OCT spectrometer, Cobra-S, offering unbeatable ultra-high speeds of 250,000 lines per second and enhanced roll-off performance for deeper sample penetration with the highest image clarity. The Cobra-S can be designed into near infrared OCT systems for research and OEM applications. A part of the Wasatch Photonics’ industry-leading Cobra spectrometer line, the Cobra-S is designed for a wide variety of spectral-domain OCT applications including ophthalmology, dermatology, angiography, oncology and industrial use. “Cobra-S is the result of our commitment to provide researchers and industry partners with the latest technology that enables and drives new applications ...

      Read Full Article
      Mentions: Wasatch Photonics Nishant Mohan

    24. Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Explore Avinger Cardiology , Other Business News
      Avinger Announces 24-Month Outcomes from the Pivotal VISION Study of Lumivascular Technology for Peripheral Artery Disease

      Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced positive two-year clinical data from the pivotal VISION study of the company’s Lumivascular™ technology. The VISION study was designed to evaluate the safety and effectiveness of Avinger’s Pantheris™ system to perform directional atherectomy while for the first time ever allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Data from the study, which demonstrated successful achievement of all primary and secondary safety and effectiveness endpoints, supported U.S. Food and Drug ...

      Read Full Article
      Mentions: University of Graz FDA Avinger
    1-24 of 1028 1 2 3 4 ... 41 42 43 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. Popular Articles

  5. OCT Companies in the News

    1. (1 articles) Optovue